Pregled bibliografske jedinice broj: 818731
Endothelins -- clinical perspectives
Endothelins -- clinical perspectives // Biochemia medica : časopis hrvatskoga društva medicinskih biokemičara, 21 (2011), 3; 231-242 doi:10.11613/BM.2011.032 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 818731 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Endothelins -- clinical perspectives
Autori
Unić, Adriana ; Derek, Lovorka ; Hodak, Nataša ; Marijančević, Domagoj ; Čeprnja, Marina ; Serdar, Tihana ; Krhač, Maja ; Romić, Željko
Izvornik
Biochemia medica : časopis hrvatskoga društva medicinskih biokemičara (1330-0962) 21
(2011), 3;
231-242
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
endothelin 1 ; endothelin receptor ; endothelin receptor antagonist ; endothelin converting enzyme
Sažetak
Endothelins (ET) are a group of endogenous peptides, which have a strong and long-lasting vasoconstrictive effect. Three isoforms of endothelins coded by three different genes have been identified to date. Endothelin-1 (ET-1) is the most potent vasoconstrictive agent currently identified, and it was originally isolated and characterized from the culture media of aortic endothelial cells. Two other isoforms, named endothelin-2 (ET-2) and endothelin-3 (ET- 3), were subsequently identified, along with structural homologues isolated from the venom of Actractapis engaddensis known as the sarafotoxins. The biological effects of endothelin production are determined via activation of one or two G- protein coupled receptors, endothelin receptors A (ETRA) and B (ETRB1 and ETRB2). Recently endothelin receptor C (ETRC) was discovered, however, its functions and distribution still remain unclear. The effects mediated by ET-1 via ETRA are vasoconstriction, bronchoconstriction and secretion of aldosterone. Agonists related to the ETRB1 activation cause vasodilatation by stimulating NO, PGI2 and endothelium- derived hyperpolarizing factor (EDHF). In contrast, coupling to ETRB2 causes vasoconstriction. Involvement of ET has been demonstrated in the pathophysiology of certain disorders. In this review, we discuss the physiological and pathophysiological role of endothelium-derived ET-1, the pharmacology of its two receptors, focusing on the role of ET-1 in the development of some pathophysiological conditions.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinička bolnica "Dubrava"
Profili:
Tihana Serdar Hiršl
(autor)
Adriana Unić
(autor)
Domagoj Marijančević
(autor)
Željko Romić
(autor)
Lovorka Đerek
(autor)
Marina Čeprnja
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE